Table of Content
Summary
This document sets your entire deal framework
It's the non-binding document that sets every economic and governance term before legal documentation begins. Getting this right matters more than the press release.
[01]
Valuation fixation is the most expensive founder mistake
Founders fixate on the number. Investors focus on liquidation preferences, anti-dilution protection, and board control. That gap is where founders lose money.
[02]
1x non-participating preferred is your negotiation baseline
In Q2 2025, 95% of VC deals used non-participating preferences. Anything else is an exception you should push back on explicitly.
[03]
Your cap table changes more than you realize
SAFEs, option pool expansions, and conversion mechanics shift founder ownership significantly beyond the stated dilution percentage in the term sheet.
[04]
Close takes 45 to 90 days, not two weeks
Founders consistently underestimate this timeline. Definitive agreements, due diligence, and legal negotiation are where deals get complicated and sometimes fall apart.
[05]
The first thing founders celebrate about a term sheet is the valuation. I get why.
It's the number that ends up in the announcement. The one you tell your co-founder about when the email lands.
It's also, in my experience, the least consequential number on the page.
I've reviewed or worked directly on over 30 capital raises in the past two years. The founders who ended up with significantly less than they'd expected rarely traced the problem back to valuation.
They traced it back to liquidation preferences they'd agreed to without fully understanding. To option pool expansions calculated in the most dilutive way possible. To protective provisions that gave investors veto power over decisions founders assumed were theirs to make.
A term sheet's non-binding. What that means in practice: it's cheap to sign.
What most founders don't realize: once you've signed, renegotiating is nearly impossible without destroying the relationship. The deal's effectively set.
This post covers what actually determines your outcome in a term sheet. And where the negotiation you think is coming has already happened.
Key terms you should know
You need the vocabulary before you sign anything. Not because it's intellectually interesting, but because the language in a term sheet determines what your equity actually means.
These aren't background reading. They're the exact language you'll need when you're reviewing the document with your lawyer. Read a sample term sheet template before your first raise so you've learned the vocabulary before the pressure starts, not during it.
Term sheet: A non-binding document outlining the key terms of a proposed investment. Call it non-binding and you'll miss the point: once you sign, you've committed to the economic and governance framework that governs every agreement that follows.
Liquidation preference: The right investors hold to receive a defined return before common shareholders in any exit event: sale, merger, or wind-down. The structure, participating or non-participating, is one of the most consequential choices you'll make.
Participating preferred: A structure where investors receive their liquidation preference and then also share in remaining proceeds alongside common shareholders. Meaning they win twice. This is the provision most founders misread.
Anti-dilution: Provisions that protect investor ownership percentage if you raise a future round at a lower valuation. Broad-based weighted average is the standard form. Full ratchet is the clause that can devastate founder equity.
Protective provisions: Rights that give investors veto power over specific company decisions: new fundraising, acquisitions, changes to the cap table. The scope of these provisions is negotiable and frequently too broad in first drafts.
No-shop clause: A period after signing during which founders cannot negotiate a competing term sheet from another investor. Standard duration: 30 to 45 days. Anything beyond 60 days without a clear termination provision is worth pushing back on.
What is a term sheet?
A term sheet is non-binding. That means neither side's legally committed to closing.
But calling it non-binding misses what really matters. You've committed to the economic and governance structure that governs every legal document that follows. That distinction matters more than founders realize.
It's why the clauses buried on page 8 matter as much as the valuation on page 1. The non-binding label is one of the most misleading phrases in startup finance.
Every term sheet divides into two categories.
Economic terms define the financial mechanics: valuation, investment amount, ownership stake, liquidation preferences, anti-dilution protections, and how the option pool's sized.
Control terms define who decides what: board composition, voting rights, protective provisions, information rights, and pro-rata participation in future rounds.
Most founders encounter their first term sheet during seed or early Series A when they've got the least context for what's standard versus unusual. Know the difference between a template baseline and an actual negotiated document.
This information gap is why investors are better positioned. You don't have to stay that way.
The national venture capital association term sheet is the baseline for most US VC deals. Read it before you get your first term sheet.
Understand where you're raising in the broader startup funding stages too. Earlier rounds don't play by the same rules as later-stage deals.
Why is valuation the wrong term to focus on?
The conventional wisdom in startup fundraising is that valuation is everything.
Protect your dilution
Get the highest number before the market moves
It's a reasonable instinct, and the wrong one to act on when you're sitting across from a term sheet.
A founder came to me several months into his Series B preparation. He'd raised £4.2M at a £16M pre-money valuation in his Series A, roughly 26% dilution on that round. He'd tracked this carefully and was satisfied with the number.
But when we built the Series B cap table together, his ownership had dropped from 60% at Series A close to 37%. He was confused. He'd tracked the headline dilution correctly.
What he hadn't tracked: the SAFE notes from his pre-seed round, which hadn't yet converted and had accumulated additional value since issuance, plus the option pool expansion his Series A lead required calculated pre-money.
Those two items removed another 18 percentage points from founder and common equity that weren't visible in the term sheet headline. The term sheet was clean. The problem was in the documents around it, the ones nobody read together before signing.
Bloomberg data shows that median European rounds grew 32% in a year, with most new term sheets arriving from American investors offering higher valuations and more founder-friendly economics on paper. What the coverage doesn't highlight: the governance expectations and growth pace commitments attached to those term sheets are structurally different from what European founders typically negotiate domestically.
The valuation headline is real. The governance section is different. Founders who accept US term sheets without reading the control provisions carefully often find out six months into the relationship what they actually agreed to.
I've seen founders celebrate a 20% better valuation on a term sheet that also included participating preferred stock. Run the exit math on any outcome below £80M and the participating structure costs them more than the valuation uplift ever gave back.
Founders assume a higher pre-money valuation means a better deal. In practice,
A \$10M pre-money with a 1x non-participating liquidation preference will outperform a \$15M pre-money with 1x participating preferred in nearly every exit scenario below \$100M.
Before negotiating valuation, understand the pre-money vs post-money valuation mechanics. The calculation method shapes how much the number actually means once you account for the full cap table stack.
The economic terms that actually determine your exit
Below the valuation line sit three provisions that carry more impact on founder outcomes than any other section. Most founders spend less than 20 minutes on them. Total.
Liquidation preferences
A liquidation preference sets the repayment order when the company exits:
Sale
Merger
Wind-down.
A 1x non-participating liquidation preference means investors get the greater of their original investment or their pro-rata share if they convert to common stock.
In strong exits, investors typically convert to common and take the higher number.
In modest exits, they take the preference.
This structure is fair and predictable. It's the standard for a reason: protects investors without letting them double-dip on upside.
The trouble starts with participating preferred. Investors take their preference first. Then they also participate alongside common shareholders in the remaining proceeds.
According to Cooley reported that 98% of venture deals use a 1x liquidation preference and 95% are non-participating as of Q2 2025. If you're asked to accept participating preferred at seed or Series A, you have grounds to push back. Hard.
Structure | Investor receives | Founder-friendly? | Market standard? |
|---|---|---|---|
1x non-participating | Original investment OR pro-rata share (higher of the two) | Yes | Yes (95% of deals) |
1x participating | Original investment PLUS pro-rata share of remainder | No | Off-market at seed/A |
2x non-participating | 2x original investment OR pro-rata share (higher) | No | Red flag in early rounds |
Full ratchet anti-dilution | Entire position repriced to new (lower) round price | No | Hard red line: avoid |
Option pool mechanics
Every VC-backed term sheet includes an option pool, a reserved block of equity for future employees and advisors. The issue isn't the pool itself. It's when and how it's calculated.
When investors require the pool to be built or expanded before the investment is priced, it comes entirely out of founder and common equity.
A 15% option pool on a \$10M pre-money deal costs founders roughly $1.5M in equity value before close. That math doesn't show up in the headline dilution percentage.
Push for the option pool to be calculated post-money, or negotiate the size down to what the business plan genuinely requires for the next 12 to 18 months. Investors routinely ask for larger pools than the hiring plan justifies. It's a negotiating point, not a fixed requirement.
Anti-dilution provisions
Broad-based weighted average anti-dilution is standard in 2026. It adjusts investor ownership based on a formula accounting for all shares outstanding. This limits the dilutive impact on founders and employees if a down round occurs.
According to Series A term sheet surveys consistently show full ratchet anti-dilution appearing in fewer than 5% of standard early-stage deals. Full ratchet reprices the investor's entire position to the new lower price in a down round. It can wipe out significant founder and employee equity. There's no justification for accepting it at seed or Series A.
The math is worth understanding, and these calculations aren't in the term sheet template. Say an investor buys 2,000,000 shares at $5 per share. You raise a down round at $2.50 per share.
With broad-based weighted average anti-dilution, their conversion price adjusts modestly downward, taking into account all shares outstanding.
With full ratchet? Their entire 2,000,000 shares automatically reprice to $2.50. The company must issue them an additional 2,000,000 shares to maintain their original economic value.
That dilution comes directly from everyone else on the cap table: founders, employees, and earlier investors without full ratchet protection. Founders who accepted full ratchet in bridge rounds sometimes find themselves minority shareholders before their Series A even closes.
Pro-rata rights
Pro-rata rights, the right to invest in future rounds to maintain ownership percentage, are standard and generally fair. The scope matters though. An investor with uncapped pro-rata rights on a 10% position can consume significant allocation in your Series B or C.
It reduces the room for new institutional investors who want meaningful ownership.
Negotiate pro-rata rights to a defined cap, typically the investor's percentage at the time of the next round.
Unlimited pro-rata participation is reasonable to push back on, especially if you anticipate a large Series B with competitive interest.
Super pro-rata rights are a separate ask worth scrutinizing. These allow an investor to increase their ownership percentage in a follow-on round beyond their current stake.
Some angel investors and micro-VCs request super pro-rata rights as their standard ask. Before agreeing, model how that allocation affects your ability to bring in a strong lead for your next round. A lead investor who needs 15 to 20% to get excited about your deal can't get there if super pro-rata rights have consumed that allocation.
I recently sat with Armon Sharei, former founder of SQZ Biotechnologies and current CEO of Portal Bio and there was a very interesting story that describes the impulse buy nature of early-stage angel investing. Watch now.
Which term sheet terms should founders actually negotiate?
Most founders approach term sheet terms negotiations with one number in mind. That's not negotiating.
Worse, it puts you at a disadvantage. Know which clauses are actually negotiable versus market-standard. This difference separates founders who close clean rounds from those who spend years untangling what they've signed.
What's market standard: accept without burning capital
Standard 2026 market-rate terms:
1x non-participating liquidation preference
Broad-based weighted average anti-dilution
4-year vesting with a 1-year cliff
Standard information rights
Pro-rata rights for the lead.
Pushing back on these signals inexperience without gaining ground. Save your negotiating capital for the provisions that actually move your long-term outcome.
The SVB guide on reading a term sheet makes the point directly: the most important factor in a term sheet often isn't a legal one at all. It's the investor sitting across from you. Terms are negotiable, but the relationship you're entering isn't.
What's genuinely negotiable?
Board composition is where control terms live. The standard early-stage structure's a three-person board: one founder, one investor, one independent. Push back on two-investor-seat arrangements before you've built the working relationship to make that safe.
The cleanest term sheet I've reviewed recently stated: post-money valuation, all SAFEs convert before close, three-person board with an independent both parties approve jointly. No ambiguity anywhere on the cap table. The founder knew exactly where they stood from day one.
No-shop duration matters more than founders realize.
Standard exclusivity: 30 to 45 days. If an investor asks for 60 days or more, ask directly why they need that window.
An open-ended no-shop without a termination provision removes your negotiating position entirely if the deal slips. You can't restart conversations with other investors. The lead investor knows it.
Option pool size and calculation method are worth 30 minutes of deliberate negotiation.
An 18% option pool calculated pre-money on a $10M deal costs founders roughly $1.8M in equity value before close. The same 18% post-money costs meaningfully less.
Founders accept the pre-money calculation without questioning it too often. Ask your lawyer to model both scenarios before you talk with your investor.
The difference is rarely dealbreaking. Knowing the number puts you in a better position to negotiate.
Protective provision scope's the underrated fight. First drafts often include investor veto rights on things like executive compensation above threshold, new equity incentive plans, and entering new business lines. These are operational decisions, not investor protection.
Push for protective provisions to cover only genuinely major transactions:
Raising more capital
Issuing new stock classes
Selling the company
Changing the charter.
Anything beyond that encroaches on your ability to run the business.
Join Raise or Die Newsletter. Cancel anytime.
What do founders get wrong about term sheets?
Founders consistently make the same term sheet mistakes. Not because the documents are technically difficult. Because nobody's prepared them for which assumptions to question before they sat down.
Founders assume they can negotiate everything. In practice, the term sheet establishes the framework. Once it's signed, both sides anchor to it.
The investors' lawyers draft the definitive agreements to reflect the term sheet. The founders' lawyers work from the same document. The negotiating range largely closes.
Founders assume the non-binding nature means low stakes at term sheet stage.
What actually happens: everything agreed in principle survives into the definitive agreements with minimal change.
Asking an investor to revise participating preferred after you've signed doesn't restart negotiations. It restarts the question of whether you're the right kind of founder to work with.
Founders assume a signed term sheet means close is coming soon.
Standard close runs 30 to 90 days from signature, and that's when nothing goes wrong.
Legal documentation
Final due diligence
SAFE conversions
Definitive agreement negotiations extend this consistently.
I had a founder call me six weeks after signing, frustrated his deal hadn't closed. He'd been told two to three weeks.
We were still negotiating the indemnification clause in the shareholders' agreement on week seven. Delays like this are normal on complex deals.
Founders assume all 1x liquidation preferences are equivalent. The difference between 1x non-participating and 1x participating preferred's significant in any exit below \$100M. A \$5M investor with 1x non-participating who owns 20% of a company exiting at $30M collects roughly $6M, converting to common stock.
The same investor with 1x participating collects their $5M preference plus 20% of the remaining $25M, approximately $10M total. The founder's share changes by $4M on a \$30M exit. Venture capital term sheet analysis consistently identifies this as the most misunderstood provision in early-stage documents.
The non-binding label on a term sheet is one of the most misleading phrases in startup finance. Once an investor has committed to your valuation, terms, and structure in writing, even non-binding writing, the psychological and practical cost of renegotiating is nearly identical to walking away from the deal.
Red flags that should stop you signing
Most term sheets from credible investors are clean. The provisions below appear rarely in standard early-stage rounds. When they do, they warrant a direct conversation before anything gets signed.
Participating preferred stock, especially at 2x or higher.
This is off-market in virtually all seed and Series A rounds and has been for several years.Full ratchet anti-dilution. If you raise at a lower valuation later, this reprices the investor's entire position to the new price, a provision that can eliminate most employee equity in a single down round.
Cumulative dividends. Accruing dividends on preferred stock compound even if the company never declares them, increasing investor preferences over time and reducing common shareholder proceeds at exit.
Redemption rights. The right for investors to demand their capital back after a set period. Unusual in standard VC deals and capable of creating forced liquidity pressure at the worst possible moment.
No-shop clauses beyond 60 days without clear termination provisions. Open-ended exclusivity gives investors unlimited negotiating power if they decide to slow-walk the close.
Investor-majority board composition from day one. A board where investors hold the majority before a trust-based working relationship exists creates structural risk on decisions that should involve founder judgment.
According to Governance section veto rights over major company decisions live there. When WeWork's governance structure gave SoftBank effective blocking power on key board decisions without founder protections, the board couldn't intervene before the IPO process exposed the full extent of the problem.
Governance provisions don't generate headlines. They prevent them.
What happens after the term sheet is signed?
Signing a term sheet marks the beginning of the legal process. Founders who treat the signature as the close get surprised by what comes next. They end up with less favorable definitive agreements than the term sheet implied.
After the term sheet you enter documentation and diligence. This includes negotiating the definitive agreements: the stock purchase agreement, investor rights agreement, right of first refusal and co-sale agreement, and the voting agreement.
These are four separate documents. Each has provisions that operationalize the term sheet language into enforceable obligations.
Final financial and legal due diligence run in parallel. Any required regulatory filings, closing conditions, and the fund transfer all come after the legal docs are signed. Standard timeline from signed term sheet to close: 30 to 90 days, with complex deals running longer. Understanding the difference between a term sheet and a letter of intent matters too. They're used in different contexts with different implications for exclusivity and commitment.
Between signing and closing is the right time to get any side agreements, board observer rights, or information rights explicitly documented. Don't rely on informal understanding.
Verbal commitments made during term sheet discussions don't carry legal weight in the definitive agreements. If an investor promised you something during negotiations, get it in writing before you're deep into due diligence and the power dynamics have shifted.
There are six things worth doing immediately after signing:
Confirm the investor has completed their internal investment committee approval, since a signed term sheet doesn't always mean IC has formally voted
Engage your startup transaction lawyer now, not after the first draft of the definitive agreements arrives
Open a clean data room with all the documents the investor's counsel will request in diligence
Begin negotiating the definitive agreements separately from the term sheet, since this is where the real legal work happens
Ensure all outstanding SAFEs and convertible notes are modeled in your cap table before close, so there are no ownership surprises
Set a clear closing date target and monitor slippage weekly, since extended timelines often signal something the investor's counsel has flagged
A good lawyer who knows startup transactions isn't optional. Running the definitive agreement process without specialist counsel to save fees is consistently the most expensive post-signing mistake founders make.
My direct assessment
Say it plainly: the term sheet phase isn't administrative. It's where your company's economic and governance structure for the next five to ten years gets locked in.
The terms you agree to here form the skeleton of every legal document that follows. They're far easier to negotiate now than after both parties have committed in writing.
Founders who treat the term sheet like a formality call two years later confused about why their ownership's a fraction of what they expected. The terms that govern your life after the deal closes aren't in the press release.
They're in the liquidation waterfall. They're in the protective provisions. They're in board composition clauses most founders skim past on page 8.
Most of the time those clauses are exactly where the lead investor's lawyers focused their attention when drafting. That's not adversarial.
It's just how deals get structured. The information asymmetry is real. It runs in one direction.
There's also a meaningful market shift worth tracking. IPO ratchets appeared in approximately 15% of Series B+ term sheets in 2025, a provision virtually absent two years ago.
Structured deals with compounding liquidation preferences or PIK dividends have become more common in later-stage rounds. These aren't early-stage concerns yet. Founders who understand term sheets now'll recognize them when they appear at the next round.
A term sheet is the test of how well you understand the game you're playing. Founders who read every clause negotiate better deals and carry less structural risk into their next fundraise. The ones who focus only on the valuation line find out what they actually agreed to at the Series B close, and by then there's not much to renegotiate.
Reviewing term sheets and advising on capital raise structure is part of what spectup does. Working with a fundraising consultant who's sat on both sides of these negotiations means you've got context for what's standard, what's negotiable, and what's worth walking away from.
For institutional capital and larger private placements, the private placement agent structure adds a layer of deal structuring experience. If you're at term sheet stage and want a second opinion before signing, book a call.
Founders who read the full term sheet always call back. The ones who skip straight to the valuation line also call back. The conversations are very different.
Concise Recap: Key Insights
Valuation isn't the term that matters most
Liquidation preferences, anti-dilution provisions, and board control clauses together determine your actual exit outcome far more than the headline valuation.
98% of VC deals use 1x non-participating preference
Participating preferred and full ratchet anti-dilution are off-market terms in most early-stage rounds. Signing them signals you didn't negotiate hard enough.
Term sheet to close takes longer than you expect
Budget 45 to 90 days after signing. Rushing this phase produces poorly negotiated definitive agreements that create problems at your next round.
Frequently Asked Questions
What is term sheet in fundraising?
A term sheet is a non-binding document that sets the key economic and governance terms of a proposed investment before formal legal documentation begins. It covers valuation, investment amount, ownership stake, liquidation preferences, board composition, and investor rights. Most term sheets run 5 to 15 pages and are signed before due diligence formally closes. Understanding what is a term sheet template versus the negotiated document you receive matters: the NVCA template is the standard US baseline, and deviations from it are the provisions worth understanding. Any clause that doesn't appear in the template deserves a direct question about why it's included.
